U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653906) titled 'Coeliac Plexus vs Splanchnic Nerve Neurolysis for Upper Abdominal Cancer Pain' on June 12.

Brief Summary: The goal of this clinical trial is to determine whether Neurolytic Splanchnic Nerve Block (NSNB) reduces pain in adults with upper abdominal malignancies. It will also evaluate the safety of Neurolytic Splanchnic Nerve Block (NSNB). The main questions it aims to answer are:

Does NSNB reduce pain intensity compared to Neurolytic Coeliac Plexus Block (NCPB), as measured by the Visual Analog Scale (VAS)? What adverse effects do participants experience when receiving Neurolytic Splanchnic Nerve Block (NSNB)?

Investigators will com...